MARKSANS PHARMA LTD.
Market Cap.(`)
|
7470.40 Cr.
|
P/BV
|
4.28
|
Book Value (`)
|
38.51
|
52 Week High/Low ( ` )
|
186/71
|
FV/ML
|
1/1
|
P/E(X)
|
28.05
|
Book Closure
|
07/06/2023
|
EPS (`)
|
5.88
|
Div Yield (%)
|
0.30
|
You can view the
Consolidated
Ratio Analysis
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 6.41 | 4.51 | 5.76 | 2.86 | 1.87 |
Diluted EPS (Rs.) | 6.41 | 4.51 | 5.76 | 2.86 | 1.87 |
Cash EPS (Rs.) | 7.00 | 5.66 | 6.71 | 3.60 | 2.52 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 38.95 | 29.88 | 22.12 | 15.86 | 13.50 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 38.95 | 29.88 | 22.12 | 15.86 | 13.50 |
Revenue From Operations / Share (Rs.) | 40.87 | 36.42 | 33.62 | 27.71 | 24.43 |
PBDIT / Share (Rs.) | 8.80 | 7.35 | 8.46 | 4.70 | 3.34 |
PBIT / Share (Rs.) | 7.65 | 6.25 | 7.58 | 4.05 | 2.78 |
PBT / Share (Rs.) | 7.45 | 6.05 | 7.38 | 3.84 | 2.55 |
Net Profit / Share (Rs.) | 5.85 | 4.56 | 5.83 | 2.95 | 1.97 |
NP After MI And SOA / Share (Rs.) | 5.88 | 4.56 | 5.83 | 2.95 | 1.97 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 21.52 | 20.17 | 25.16 | 16.97 | 13.67 |
PBIT Margin (%) | 18.72 | 17.16 | 22.53 | 14.62 | 11.39 |
PBT Margin (%) | 18.23 | 16.60 | 21.95 | 13.85 | 10.42 |
Net Profit Margin (%) | 14.32 | 12.53 | 17.33 | 10.64 | 8.04 |
NP After MI And SOA Margin (%) | 14.37 | 12.53 | 17.33 | 10.64 | 8.04 |
Return on Networth / Equity (%) | 15.25 | 15.53 | 26.90 | 18.98 | 14.82 |
Return on Capital Employeed (%) | 18.75 | 19.93 | 33.35 | 24.62 | 19.95 |
Return On Assets (%) | 12.15 | 11.39 | 19.42 | 13.37 | 10.00 |
Total Debt / Equity (X) | 0.02 | 0.03 | 0.02 | 0.02 | 0.18 |
Asset Turnover Ratio (%) | 0.96 | 1.04 | 0.73 | 0.61 | 0.63 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 4.91 | 3.37 | 3.02 | 2.59 | 2.28 |
Quick Ratio (X) | 3.49 | 2.18 | 1.67 | 1.54 | 1.02 |
Inventory Turnover Ratio (X) | 1.35 | 1.30 | 1.74 | 1.14 | 1.44 |
Dividend Payout Ratio (NP) (%) | 3.81 | 5.47 | 1.71 | 24.43 | 5.52 |
Dividend Payout Ratio (CP) (%) | 3.19 | 4.41 | 1.49 | 20.01 | 4.30 |
Earning Retention Ratio (%) | 96.19 | 94.53 | 98.29 | 75.57 | 94.48 |
Cash Earning Retention Ratio (%) | 96.81 | 95.59 | 98.51 | 79.99 | 95.70 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 43.67 | 35.61 | 43.36 | 22.02 | 14.16 |
Interest Coverage Ratio (Post Tax) (%) | 30.07 | 23.12 | 30.87 | 14.81 | 9.33 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 2540.86 | 1577.14 | 1869.83 | 507.17 | 1103.73 |
EV / Net Operating Revenue (X) | 1.37 | 1.06 | 1.36 | 0.44 | 1.10 |
EV / EBITDA (X) | 6.37 | 5.24 | 5.40 | 2.63 | 8.07 |
MarketCap / Net Operating Revenue (X) | 1.72 | 1.25 | 1.49 | 0.50 | 1.02 |
Retention Ratios (%) | 96.18 | 94.52 | 98.28 | 75.56 | 94.47 |
Price / BV (X) | 1.83 | 1.55 | 2.31 | 0.89 | 1.87 |
Price / Net Operating Revenue (X) | 1.72 | 1.25 | 1.49 | 0.50 | 1.02 |
EarningsYield | 0.08 | 0.10 | 0.11 | 0.21 | 0.07 |